 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 02/02/2026 |
$2.67 |
$2.72 |
$2.46 |
$2.49 |
750.50K | | 02/03/2026 |
$2.55 |
$2.57 |
$2.20 |
$2.40 |
716.90K | | 02/04/2026 |
$2.41 |
$2.42 |
$2.18 |
$2.21 |
291.40K | | 02/05/2026 |
$2.16 |
$2.23 |
$1.90 |
$1.96 |
454.70K | | 02/06/2026 |
$2.03 |
$2.23 |
$2.03 |
$2.20 |
277.00K |
|
|
| Genprex, Inc. is a clinical-stage gene therapy company focused on developing therapies for patients with cancer and diabetes. Co.'s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes, who have limited treatment options. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid nanoparticles. Co.'s lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). | |
|
Genprex (GNPX) has the following price history information. Looking back at GNPX historical stock prices for the last five trading days, on February 02, 2026, GNPX opened at $2.67, traded as high as $2.72 and as low as $2.46, and closed at $2.49. Trading volume was a total of 750.50K shares. On February 03, 2026, GNPX opened at $2.55, traded as high as $2.57 and as low as $2.20, and closed at $2.40. Trading volume was a total of 716.90K shares. On February 04, 2026, GNPX opened at $2.41, traded as high as $2.42 and as low as $2.18, and closed at $2.21. Trading volume was a total of 291.40K shares. On February 05, 2026, GNPX opened at $2.16, traded as high as $2.23 and as low as $1.90, and closed at $1.96. Trading volume was a total of 454.70K shares. On February 06, 2026, GNPX opened at $2.03, traded as high as $2.23 and as low as $2.03, and closed at $2.20. Trading volume was a total of 277.00K shares.
GNPX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Genprex shares, starting with a $10,000 purchase of GNPX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/02/2018 |
|
| End date: |
02/06/2026 |
|
| Start price/share: |
$9,000.00 |
|
| End price/share: |
$2.20 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.98% |
|
| Average Annual Total Return: |
-65.31% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$2.45 |
|
| Years: |
7.85 |
|
|
|
| Date |
Close |
| 02/02/2026 | $2.49 | | 02/03/2026 | $2.40 | | 02/04/2026 | $2.21 | | 02/05/2026 | $1.96 | | 02/06/2026 | $2.20 |
|
|
Free GNPX Email Alerts:
